Equity Overview
Price & Market Data
Price: $0.61
Daily Change: -$0.0199 / 3.26%
Daily Range: $0.586 - $0.625
Market Cap: $5,523,969
Daily Volume: 132,870
Performance Metrics
1 Week: -18.81%
1 Month: -48.33%
3 Months: -49.19%
6 Months: -64.55%
1 Year: -89.11%
YTD: -45.56%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.